Valuation: Sirnaomics Ltd.

Market Cap 54.99M 431M 47.81M 44.5M 40.85M 77.15M 5.25B 78.34M 525M 206M 2.61B 207M 202M 8.76B P/E 2024
-0.67x
P/E 2025 -6.46x
Enterprise Value 50.79M 398M 44.15M 41.1M 37.73M 71.25M 4.85B 72.36M 484M 190M 2.41B 191M 187M 8.09B EV / Sales 2024
24.1x
EV / Sales 2025 -
Free-Float
74.83%
Yield 2024 *
-
Yield 2025 -
1 day-2.27%
1 week-3.25%
Current month-2.27%
1 month-14.00%
3 months-36.45%
6 months-51.93%
Current year-49.54%
1 week 3.66
Extreme 3.665
4.2
1 month 3.66
Extreme 3.665
4.83
Current year 3.66
Extreme 3.665
10.72
1 year 3.66
Extreme 3.665
22.78
3 years 2.35
Extreme 2.35
56
5 years 2.35
Extreme 2.35
101
10 years 2.35
Extreme 2.35
101
Manager TitleAgeSince
Chief Executive Officer 48 2024-11-05
Director of Finance/CFO 35 2021-08-31
Compliance Officer 73 2019-12-31
Director TitleAgeSince
Chairman 48 2025-11-30
Director/Board Member 56 2025-02-16
Director/Board Member 50 2025-07-02
Date Insider Type Main position Quantity % Market Cap.
11/24/24 Other

Chief Executive Officer

12,067 0.0138%
6/5/24 Other

Executive/Senior Manager

5,000 0.0057%
5/22/24 Other

Executive/Senior Manager

5,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%-3.25%-51.50%-92.99% 54.99M
+2.35%+2.74%+38.10%+74.02% 56.54B
-0.21%-7.38%+27.52%+63.59% 53.6B
-2.44%+1.40%-15.61%-13.72% 22.91B
-2.85%-7.78%-9.28%+352.92% 21.37B
-0.88%-0.62%+23.06%-15.28% 20.27B
+0.79%-1.06%+33.99%-30.63% 17.56B
-2.77%-8.32%+16.48%+546.26% 14.75B
+3.41%-6.61%+162.81%+287.77% 13.53B
-5.25%-4.23%+42.32%+160.72% 13.33B
Average -1.00%-3.51%+26.79%+133.27% 23.39B
Weighted average by Cap. -0.26%-2.96%+30.55%+119.96%

Financials

2024 2025
Net sales 1.78M 13.94M 1.55M 1.44M 1.32M 2.49M 170M 2.53M 16.96M 6.66M 84.5M 6.68M 6.53M 283M -
Net income -51.38M -403M -44.67M -41.58M -38.17M -72.08M -4.91B -73.2M -490M -192M -2.44B -193M -189M -8.19B -14.4M -113M -12.52M -11.65M -10.7M -20.21M -1.37B -20.52M -137M -53.91M -684M -54.09M -52.9M -2.3B
Net Debt -3.71M -29.1M -3.23M -3M -2.76M -5.21M -354M -5.29M -35.39M -13.89M -176M -13.94M -13.63M -591M -4.2M -32.97M -3.65M -3.4M -3.12M -5.9M -401M -5.99M -40.1M -15.74M -200M -15.79M -15.44M -670M
Logo Sirnaomics Ltd.
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a multi-targeted siRNA therapeutic advancing clinical development across two oncology indications: squamous cell carcinoma in situ (isSCC) and basal cell carcinoma (BCC). Its STP707 is an intravenous siRNA therapeutic being evaluated in phase I clinical trial for multiple solid tumors, including colorectal, pancreatic, liver, and metastatic melanoma cancers. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.
Employees
-
Date Price Change Volume
26-08-02 HK$3.870 -2.27% 47,600
26-07-31 HK$3.960 +0.76% 44,405
26-07-30 HK$3.930 +0.77% 137,100
26-07-29 HK$3.900 -0.76% 35,400
26-07-28 HK$3.930 -1.75% 48,850
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5050USD
Average target price
9.200USD
Spread / Average Target
+1,721.79%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2257 Stock